Approvals/TGA/KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial

Approved

STANDARD

KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 36d0b8fd368599ef
Product Name: KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial
Artg Id: 263932
Artg Name: KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2016-03-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REPI
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01513-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01512-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

36d0b8fd368599ef

Type

Standard